European Single-Center Experience Using In Situ Fenestration TEVAR in Treating the Aortic Arch Pathologies

医学 主动脉弓 围手术期 外科 穿孔 胸主动脉 主动脉夹层 颈总动脉 解剖(医学) 主动脉 单中心 主动脉瘤 主动脉修补术 放射科 颈动脉 冲孔 材料科学 冶金
作者
Marwan Youssef,Meera Gunaseelan,Feras Jawish,Sina Moshar
出处
期刊:Journal of Endovascular Therapy [SAGE Publishing]
卷期号:33 (4): 1886-1892 被引量:3
标识
DOI:10.1177/15266028251316780
摘要

Background: We demonstrate our experience and outcomes of in situ fenestration (ISF) using a dedicated needle perforation device to preserve the supra-aortic vessels of the aortic arch during thoracic endovascular aortic repair (TEVAR). Methods: We included all patients with thoracic pathologies who were treated using the in situ fenestrated endografts between July 2021 and February 2024. A consecutive series of 26 patients (24 men; median age 69±10 years) received ISF TEVAR. All pathologies (16 aneurysms, 6 type B dissections, and 4 penetrating aortic ulcer [PAU]) involved the aortic arch without sufficient proximal landing zone (PLZ) distal of the left subclavian artery (LSA). Twenty-seven percent of the patients (7/26) presented in an emergent/urgent situation (symptomatic or contained rupture). One (LSA), double (LSA and left common carotid artery LCCA), and 3 (total arch) fenestrations were performed in 21, 2, and 3 patients, respectively. The perioperative and follow-up data (postoperative, 3 and 6 months, and annually) were prospectively collected. Outcomes and imaging scans were evaluated and analyzed retrospectively. Results: The technical success, defined as endovascular exclusion of the aortic arch pathology and preservation of the supra-aortic vessels using ISF, was achieved in 92% (24/26 patients). The needle perforation failed in 2 of the patients. Only one patient with aortic dissection (3.8%) had an endoleak type Ia, which resolved spontaneously after 1 month. The early perioperative neurological events occurred in 3 patients (11.5%). Two of them suffered a major stroke (7.6%). There were no mortalities in the mono and double ISF groups. However, the perioperative mortalities encountered in 2 of 3 patients in the triple ISF group, both of whom were treated due to emergent or urgent indications. The mean follow-up period was 18 months (range: 2–32). During the follow-up, 2 patients required late unplanned re-interventions (7.6%). Further transient ischemic attack occurred in one patient. No patients died due to aneurysm or procedure-related causes. At the last follow-up, no endoleaks, branch occlusion, bridging stent fractures, or dislocation were registered. Conclusion: In our experience, the use of dedicated needle device is efficacious. ISF TEVAR may serve as an initial approach as off-the-shelf endovascular treatment of the aortic arch pathologies, especially in acute situations. The triple ISF should be considered only as bailout procedure in the emergent cases. Larger series and multicenter studies are of course needed to corroborate these results. Clinical Impact Our study demonstrated the clinical impact in real-world practice of using In-situ fenestration TEVAR with the innovative dedicated perforation-needle technique, which is characterized by an immediate availability as off-the-shelf device, compatibility with the various pathologies and anatomies, as well as minimal invasiveness in comparison to the debranching bypass-procedure for the preservation of the supra-aortic vessels during the endovascular repair of aortic arch pathologies. According to center experience, this approach can applied in elective cases, however, due to its practicability, it can be especially valuable in emergencies, when the other methods are considered as an unfavorable.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
无花果的应助被恒莫采纳,获得10
刚刚
aawwzzss完成签到,获得积分10
1秒前
1秒前
今后的应助被迷人小海豚采纳,获得10
1秒前
天天快乐的应助被陈钧采纳,获得10
2秒前
暗月青影完成签到,获得积分10
2秒前
2秒前
小苏打完成签到,获得积分10
3秒前
Ariel完成签到,获得积分10
3秒前
英春发布了新的文献求助100
3秒前
瘦瘦毛豆完成签到,获得积分10
4秒前
lsq108发布了新的文献求助10
4秒前
5秒前
5秒前
卡乐瑞咩吹可完成签到,获得积分0
6秒前
大妍妍关注了科研通微信公众号
7秒前
冬瓜完成签到,获得积分10
7秒前
北极小熊发布了新的文献求助10
7秒前
shmily完成签到,获得积分10
8秒前
纪洪森发布了新的文献求助10
8秒前
Maestro_S的应助被默岩1990采纳,获得10
8秒前
8秒前
光亮寒凝完成签到 ,获得积分10
8秒前
11秒前
xeq发布了新的文献求助10
11秒前
自由文博完成签到 ,获得积分10
11秒前
小可不怕困难完成签到,获得积分10
12秒前
newwen完成签到 ,获得积分10
12秒前
祝好完成签到,获得积分10
13秒前
13秒前
13秒前
加油少年完成签到,获得积分10
15秒前
刘玉明完成签到,获得积分20
16秒前
找找发布了新的文献求助10
16秒前
英俊的铭的应助被桂花引采纳,获得10
16秒前
陈钧完成签到,获得积分10
17秒前
17秒前
辛菜头完成签到,获得积分10
18秒前
纪洪森完成签到,获得积分20
19秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185801
求助须知:如何正确求助?哪些是违规求助? 9574479
关于积分的说明 21836390
捐赠科研通 7783594
什么是DOI,文献DOI怎么找? 3434671
关于科研通互助平台的介绍 2559029
邀请新用户注册赠送积分活动 2481466